Literature DB >> 15930956

Role of macrophage tissue infiltration in metabolic diseases.

Anne Bouloumié1, Cyrile Anne Curat, Coralie Sengenès, Karine Lolmède, Alexandra Miranville, Rudi Busse.   

Abstract

PURPOSE OF REVIEW: White adipose tissue is necessary for optimal energy homeostasis and the excessive development of fat mass is clearly associated with the metabolic syndrome. The fact that adipocytes secrete a number of specific factors or 'adipokines' has forced a reassessment of the involvement of adipose tissue in a wide range of physiological and pathophysiological processes. Obesity has recently been described as a 'low-grade' inflammatory condition, a state proposed to represent a common determinator in the genesis of obesity-associated pathologies, i.e. diabetes and atherosclerosis. RECENT
FINDINGS: Recent reports of an increase in the number of macrophages that infiltrate the fat mass in obese individuals led to the suggestion that adipose tissue itself is a source and site of inflammation.
SUMMARY: This review summarizes recent data on the characterization of the macrophage population in fat tissue. Their origin, fate and activation will be considered. The potential involvement of adipose tissue macrophages in the development of insulin resistance and vascular pathologies, as well as in the control of adipose tissue growth and metabolism, will be examined.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15930956     DOI: 10.1097/01.mco.0000172571.41149.52

Source DB:  PubMed          Journal:  Curr Opin Clin Nutr Metab Care        ISSN: 1363-1950            Impact factor:   4.294


  76 in total

Review 1.  Body composition changes with testosterone replacement therapy following spinal cord injury and aging: A mini review.

Authors:  Tom E Nightingale; Pamela Moore; Joshua Harman; Refka Khalil; Ranjodh S Gill; Teodoro Castillo; Robert A Adler; Ashraf S Gorgey
Journal:  J Spinal Cord Med       Date:  2017-08-03       Impact factor: 1.985

Review 2.  Adipose tissue lymphocytes: types and roles.

Authors:  S Caspar-Bauguil; B Cousin; S Bour; L Casteilla; L Castiella; L Penicaud; C Carpéné
Journal:  J Physiol Biochem       Date:  2009-12       Impact factor: 4.158

3.  Inflamed fat: what starts the fire?

Authors:  Jaap G Neels; Jerrold M Olefsky
Journal:  J Clin Invest       Date:  2006-01       Impact factor: 14.808

Review 4.  Obesity and its therapy: from genes to community action.

Authors:  Joseph A Skelton; Laure DeMattia; Lawrence Miller; Michael Olivier
Journal:  Pediatr Clin North Am       Date:  2006-08       Impact factor: 3.278

5.  Macrophages block insulin action in adipocytes by altering expression of signaling and glucose transport proteins.

Authors:  Carey N Lumeng; Stephanie M Deyoung; Alan R Saltiel
Journal:  Am J Physiol Endocrinol Metab       Date:  2006-08-22       Impact factor: 4.310

6.  Circulating microparticles as disease-specific biomarkers of severity of inflammation in patients with hepatitis C or nonalcoholic steatohepatitis.

Authors:  Miroslaw Kornek; Michael Lynch; Shruti H Mehta; Michelle Lai; Mark Exley; Nezam H Afdhal; Detlef Schuppan
Journal:  Gastroenterology       Date:  2012-04-24       Impact factor: 22.682

7.  Evaluation of macrophage plasticity in brown and white adipose tissue.

Authors:  M Teresa Ortega; Linglin Xie; Silvia Mora; Stephen K Chapes
Journal:  Cell Immunol       Date:  2011-06-23       Impact factor: 4.868

Review 8.  Neuropeptides, mesenteric fat, and intestinal inflammation.

Authors:  Iordanes Karagiannides; Charalabos Pothoulakis
Journal:  Ann N Y Acad Sci       Date:  2008-11       Impact factor: 5.691

9.  Metabolic endotoxemia directly increases the proliferation of adipocyte precursors at the onset of metabolic diseases through a CD14-dependent mechanism.

Authors:  Elodie Luche; Béatrice Cousin; Lucile Garidou; Matteo Serino; Aurélie Waget; Corinne Barreau; Mireille André; Philippe Valet; Michael Courtney; Louis Casteilla; Rémy Burcelin
Journal:  Mol Metab       Date:  2013-07-04       Impact factor: 7.422

10.  Peripheral mononuclear cell resistin mRNA expression is increased in type 2 diabetic women.

Authors:  Panayoula C Tsiotra; Constantine Tsigos; Eleni Anastasiou; Eleni Yfanti; Eleni Boutati; Emmanouil Souvatzoglou; Ioannis Kyrou; Sotirios A Raptis
Journal:  Mediators Inflamm       Date:  2008-12-21       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.